Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pembrolizumab 200 / Paclitaxel 175 / Carboplatin 5 / Bevacizumab 15, Cervical Cancer, Cycle 1-6

Protocol-ID: 1890 V1.1 (Mini), PEMB200/PACL175/CRBP5/BEVA15, Cervical Ca, C1-6

Indication(s)

  • Cervical Cancer; ICD-10 C53.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 29.01.2023